EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    6.1.1.4 | Lung Diseases |
33558292 |
A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Anti-Mycobacterial Activity. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 6.1.1.4 | Tuberculosis |
33558292 |
A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Anti-Mycobacterial Activity. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 6.1.1.4 | Tuberculosis |
11087829 |
A prokaryote and human tRNA synthetase provide an essential RNA splicing function in yeast mitochondria. |
ongoing research
unassigned |
2
0 |
| 6.1.1.4 | Stroke |
29614877 |
A video-game group intervention: Experiences and perceptions of adults with chronic stroke and their therapists: Intervention de groupe à l'aide de jeux vidéo : Expériences et perceptions d'adultes en phase chronique d'un accident vasculaire cérébral et de leurs ergothérapeutes. |
ongoing research
unassigned |
1
0 |
| 6.1.1.4 | Onychomycosis |
17588934 |
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site. |
therapeutic application
unassigned |
3
0 |
| 6.1.1.4 | Gram-Negative Bacterial Infections |
23625818 |
An assessment of the genetic toxicology of novel boron-containing therapeutic agents. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 6.1.1.4 | Neoplasms |
27239038 |
An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter. |
unassigned |
0 |
| 6.1.1.4 | Neoplasms |
33118994 |
Avoir sa santé en main : le sentiment d'habilitation tel que perçu par les jeunes adultes souffrant d'un cancer avancé. |
unassigned |
0 |
| 6.1.1.4 | Infections |
25348524 |
Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 6.1.1.4 | Urinary Tract Infections |
25348524 |
Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
